Hulett MD - Search Results

1

Jayatilleke KM, Hulett MD. Jayatilleke KM, et al. Among authors: hulett md. J Transl Med. 2020 Nov 30;18(1):453. doi: 10.1186/s12967-020-02624-1. J Transl Med. 2020. PMID: 33256730 Free PMC article. Review.

2

Mice deficient in heparanase exhibit impaired dendritic cell migration and reduced airway inflammation.

Poon IK, Goodall KJ, Phipps S, Chow JD, Pagler EB, Andrews DM, Conlan CL, Ryan GF, White JA, Wong MK, Horan C, Matthaei KI, Smyth MJ, Hulett MD. Poon IK, et al. Among authors: hulett md. Eur J Immunol. 2014 Apr;44(4):1016-30. doi: 10.1002/eji.201343645. Epub 2014 Feb 14. Eur J Immunol. 2014. PMID: 24532362 Free article.

3

Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4.

Goodall KJ, Poon IK, Phipps S, Hulett MD. Goodall KJ, et al. Among authors: hulett md. PLoS One. 2014 Oct 8;9(10):e109596. doi: 10.1371/journal.pone.0109596. eCollection 2014. PLoS One. 2014. PMID: 25295599 Free PMC article.

4

Leukocyte Heparanase: A Double-Edged Sword in Tumor Progression.

Mayfosh AJ, Baschuk N, Hulett MD. Mayfosh AJ, et al. Among authors: hulett md. Front Oncol. 2019 Apr 29;9:331. doi: 10.3389/fonc.2019.00331. eCollection 2019. Front Oncol. 2019. PMID: 31110966 Free PMC article. Review.

5

Heparanase: Cloning, Function and Regulation.

Gaskin SM, Soares Da Costa TP, Hulett MD. Gaskin SM, et al. Among authors: hulett md. Adv Exp Med Biol. 2020;1221:189-229. doi: 10.1007/978-3-030-34521-1_7. Adv Exp Med Biol. 2020. PMID: 32274711 Review.

6

The Heparanase Regulatory Network in Health and Disease.

Mayfosh AJ, Nguyen TK, Hulett MD. Mayfosh AJ, et al. Among authors: hulett md. Int J Mol Sci. 2021 Oct 14;22(20):11096. doi: 10.3390/ijms222011096. Int J Mol Sci. 2021. PMID: 34681753 Free PMC article. Review.

7

Heparanase is a regulator of natural killer cell activation and cytotoxicity.

Mayfosh AJ, Goodall KJ, Nguyen T, Baschuk N, Hulett MD. Mayfosh AJ, et al. Among authors: hulett md. J Leukoc Biol. 2022 Jun;111(6):1211-1224. doi: 10.1002/JLB.3A0420-259RR. Epub 2021 Oct 24. J Leukoc Biol. 2022. PMID: 34693552

8

Heparanase: A Novel Therapeutic Target for the Treatment of Atherosclerosis.

Nguyen TK, Paone S, Chan E, Poon IKH, Baxter AA, Thomas SR, Hulett MD. Nguyen TK, et al. Among authors: hulett md. Cells. 2022 Oct 12;11(20):3198. doi: 10.3390/cells11203198. Cells. 2022. PMID: 36291066 Free PMC article. Review.

9

Investigating the Role of Heparanase in Breast Cancer Development Utilising the MMTV-PyMT Murine Model of Mammary Carcinoma.

Jayatilleke KM, Duivenvoorden HM, Ryan GF, Parker BS, Hulett MD. Jayatilleke KM, et al. Among authors: hulett md. Cancers (Basel). 2023 Jun 5;15(11):3062. doi: 10.3390/cancers15113062. Cancers (Basel). 2023. PMID: 37297024 Free PMC article.

10

Heparanase promotes the onset and progression of atherosclerosis in apolipoprotein E gene knockout mice.

Nguyen TK, Paone S, Baxter AA, Mayfosh AJ, Phan TK, Chan E, Peter K, Poon IKH, Thomas SR, Hulett MD. Nguyen TK, et al. Among authors: hulett md. Atherosclerosis. 2024 May;392:117519. doi: 10.1016/j.atherosclerosis.2024.117519. Epub 2024 Mar 19. Atherosclerosis. 2024. PMID: 38581737 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page